A phase I trial to determine the maximum tolerated dose and evaluate the safety and pharmacokinetics (PK) of docetaxel-PNP, polymeric nanoparticle formulation of docetaxel, in subjects with advanced solid malignancies.
Kyung Hae Jung
No relevant relationships to disclose
Kyu-Pyo Kim
No relevant relationships to disclose
Dok Hyun Yoon
No relevant relationships to disclose
Yong Sang Hong
No relevant relationships to disclose
Chang-Min Choi
No relevant relationships to disclose
Jin-Hee Ahn
No relevant relationships to disclose
Dae Ho Lee
No relevant relationships to disclose
Jae-Lyun Lee
No relevant relationships to disclose
Min-Hee Ryu
No relevant relationships to disclose
Baek-Yeol Ryoo
No relevant relationships to disclose
Heung-Moon Chang
No relevant relationships to disclose
Tae Won Kim
No relevant relationships to disclose
Sung-Bae Kim
No relevant relationships to disclose
Sang-We Kim
No relevant relationships to disclose
Cheolwon Suh
No relevant relationships to disclose
Yoon-Koo Kang
No relevant relationships to disclose
Jungsin Lee
No relevant relationships to disclose
Kyun-Seop Bae
No relevant relationships to disclose
Yong-Man Kim
No relevant relationships to disclose